{"schema_version":"secwatch.filing_event.v1","accession":"0001835268-25-000044","form_type":"8-K","ticker":"CNTB","cik":"0001835268","company_name":"Connect Biopharma Holdings Ltd","filed_at":"2025-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.224741+00:00","generated_at":"2026-05-18T05:14:57.568002+00:00","sec_items":["1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Connect Biopharma terminates ADR program; ordinary shares to list directly on Nasdaq under CNTB","bullets":["On July 18, 2025, ordered termination of Deposit Agreement with Deutsche Bank Trust Company Americas.","ADR program and Deposit Agreement expected to terminate on or about September 2, 2025.","Each ADS (1 ordinary share) will be mandatorily cancelled and exchanged for ordinary shares 1:1.","Company plans to list ordinary shares directly on Nasdaq under symbol CNTB after ADR termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001835268-25-000044","json":"https://secwatch.observer/filing/0001835268-25-000044.json","markdown":"https://secwatch.observer/filing/0001835268-25-000044.md","text":"https://secwatch.observer/filing/0001835268-25-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835268/000183526825000044/0001835268-25-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835268/000183526825000044/cntb-20250718.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:14:57.568002+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}